Your browser doesn't support javascript.
loading
Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective.
Piña-Sánchez, Patricia; Chávez-González, Antonieta; Ruiz-Tachiquín, Martha; Vadillo, Eduardo; Monroy-García, Alberto; Montesinos, Juan José; Grajales, Rocío; Gutiérrez de la Barrera, Marcos; Mayani, Hector.
Afiliación
  • Piña-Sánchez P; Oncology Research Unit, Oncology Hospital, Mexican Institute of Social Security, Mexico.
  • Chávez-González A; Oncology Research Unit, Oncology Hospital, Mexican Institute of Social Security, Mexico.
  • Ruiz-Tachiquín M; Oncology Research Unit, Oncology Hospital, Mexican Institute of Social Security, Mexico.
  • Vadillo E; Oncology Research Unit, Oncology Hospital, Mexican Institute of Social Security, Mexico.
  • Monroy-García A; Oncology Research Unit, Oncology Hospital, Mexican Institute of Social Security, Mexico.
  • Montesinos JJ; Oncology Research Unit, Oncology Hospital, Mexican Institute of Social Security, Mexico.
  • Grajales R; Department of Medical Oncology, Oncology Hospital, Mexican Institute of Social Security, Mexico.
  • Gutiérrez de la Barrera M; Oncology Research Unit, Oncology Hospital, Mexican Institute of Social Security, Mexico.
  • Mayani H; Clinical Research Division, Oncology Hospital, Mexican Institute of Social Security, Mexico.
Cancer Control ; 28: 10732748211038735, 2021.
Article en En | MEDLINE | ID: mdl-34565215
Since the second half of the 20th century, our knowledge about the biology of cancer has made extraordinary progress. Today, we understand cancer at the genomic and epigenomic levels, and we have identified the cell that starts neoplastic transformation and characterized the mechanisms for the invasion of other tissues. This knowledge has allowed novel drugs to be designed that act on specific molecular targets, the immune system to be trained and manipulated to increase its efficiency, and ever more effective therapeutic strategies to be developed. Nevertheless, we are still far from winning the war against cancer, and thus biomedical research in oncology must continue to be a global priority. Likewise, there is a need to reduce unequal access to medical services and improve prevention programs, especially in countries with a low human development index.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Investigación Biomédica / Oncología Médica / Neoplasias Tipo de estudio: Screening_studies Límite: Humans Idioma: En Revista: Cancer Control Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: México Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Investigación Biomédica / Oncología Médica / Neoplasias Tipo de estudio: Screening_studies Límite: Humans Idioma: En Revista: Cancer Control Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: México Pais de publicación: Estados Unidos